Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Leukemia, Myelogenous, Chronic, BCR-ABL Positive 32Leukemia 17Leukemia, Myeloid, Chronic-Phase 16Leukemia, Myeloid, Acute 14Breast Neoplasms 12Recurrence 11Leukemia, Lymphocytic, Chronic, B-Cell 10Prostatic Neoplasms 9Neoplasm Metastasis 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 7Blast Crisis 7Pancreatic Neoplasms 6Burkitt Lymphoma 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms 5Multiple Myeloma 5Lymphoma, Non-Hodgkin 5Glioma 5Glioblastoma 5Philadelphia Chromosome 4Myelodysplastic Syndromes 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma 4Leukemia, Myeloid, Accelerated Phase 4Gliosarcoma 4Gastrointestinal Stromal Tumors 4Colorectal Neoplasms 4Waldenstrom Macroglobulinemia 3

Interventions

apatinib 2Erlotinib Hydrochloride 2Carboplatin 2sintilimab 1durvalumab 1camrelizumab 1Vinorelbine 1Tyrosine Kinase Inhibitors 1Telescopes 1Radiotherapy 1Radiosurgery 1Pemetrexed 1Gemcitabine 1Gefitinib 1Etoposide 1Docetaxel 1Dasatinib 1Cisplatin 1Afatinib 14-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Respiratory Tract Diseases × Dasatinib × Clear all
NCT01999985 2020-11-27

Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
25 enrolled 10 charts
Thoracic

Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Pleural Diseases, Pleural Effusion, Pleural Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡